Transforming clinical trials with AI
SCOPE speaking session
In the rapidly evolving world of clinical trials, Artificial Intelligence (AI) is proving to be a game-changer. At the 2025 SCOPE conference, Chief Information, Technology, and Product Officer Jay Ferro, along with Chief Medical Officer Todd Rudo, M.D., shared how Clario is leveraging AI to enhance data precision, safeguard patient privacy, and streamline trial processes. Dive into their session to discover the ways Clario and AI are redefining the landscape of clinical research.
Topics discussed include:
- Enhancing Data Quality and Safeguarding Privacy: When applied responsibly, AI improves the accuracy and consistency of clinical trial data across various domains, such as imaging and cardiac safety. It also strengthens patient privacy by redacting personally identifiable information (PII) in compliance with regulatory standards.
- Mitigating Risks with AI: Responsible AI deployment—through comprehensive validation and rigorous testing—helps address potential risks, such as bias in algorithm training and data analysis.
- The Future of AI in Clinical Trials: AI holds immense potential to accelerate clinical trials and improve patient outcomes through precise and personalized treatments.
Discover more and watch the video below: